COMMUNIQUÉS West-GlobeNewswire

-
Affimed Places AFM11 (CD19/CD3-Targeting T cell Engager) Phase 1 Program on Clinical Hold
08/10/2018 -
Ossur Hf : Össur hf. initiates a new share buyback program
08/10/2018 -
Sanofi: Disclosure of trading in own shares
08/10/2018 -
Sanofi : Déclaration des transactions sur actions propres
08/10/2018 -
Ossur Hf : Share buyback program completed
08/10/2018 -
Novitium Pharma Launches Prazosin Hydrochloride Capsules USP
08/10/2018 -
Houston MRI® & Diagnostic Imaging Selects eRAD RIS and Portals
08/10/2018 -
ABILITY Network Announces the 2018 HomeCare Elite
08/10/2018 -
Merit Medical Systems to Announce Third Quarter Results on October 25, 2018
08/10/2018 -
Medibio Technology Honored with Two Presentations at Mayo Clinic Convergence Neuroscience 2018
08/10/2018 -
Advantis Corp. Forms New Partnership, Expands Amster-Can Branded Product Offerings
08/10/2018 -
Altimmune Announces $25 million Registered Direct Offering
08/10/2018 -
GUERBET : Information sur les opération effectuées dans le cadre du programme de rachat d'actions
08/10/2018 -
Teladoc Health to Announce Third Quarter 2018 Financial Results
08/10/2018 -
Sarepta Therapeutics Enters into Long-term Strategic Manufacturing Partnership with Paragon Bioservices, Greatly Enhancing its Commercial Capacity for Future Gene Therapies
08/10/2018 -
Letter to Shareholders from Curt Fairbrother, CEO October 8, 2018
08/10/2018 -
Golden Leaf Holdings Announces New Green Apple Flavor CBD Infused Fruit Chews
08/10/2018 -
Adamas Presents Final Results from the Two-Year, Phase 3 Open-Label Study of GOCOVRI™ in Parkinson’s Disease Patients with Dyskinesia
08/10/2018 -
International Stem Cell Corporation Doses Tenth Patient in Parkinson's Disease Clinical Trial
08/10/2018
Pages